What should define a SARS-CoV-2 “breakthrough” infection?
John S. Schieffelin, … , Elizabeth B. Norton, Jay K. Kolls
John S. Schieffelin, … , Elizabeth B. Norton, Jay K. Kolls
Published May 11, 2021
Citation Information: J Clin Invest. 2021;131(12):e151186. https://doi.org/10.1172/JCI151186.
View: Text | PDF
Viewpoint

What should define a SARS-CoV-2 “breakthrough” infection?

Abstract

Authors

John S. Schieffelin, Elizabeth B. Norton, Jay K. Kolls

×

Download this citation for these citation managers:

Or, download this citation in these formats:

If you experience problems using these citation formats, send us feedback.
Advertisement